Site intended for UK audience
Report Side Effects
LinkedIn
Global Site
Company
Portfolio
Services
Go Back
About Us
Carbon Reduction Plan
Offices
Our Medicines
Report Side Effects
Menu
Close
Contact us
Sofonac
®
Prolonged-release tablets
Active substance:
Oxycodone hydrochloride, Naloxone hydrochloride
Strength
Pack size
Dosage form
PIP CODE
PIL
SmPC
5mg/2.5mg
28
Prolonged-release tablets
428-8213
Download
Download
10mg/5mg
56
Prolonged-release tablets
428-8221
Download
Download
20mg/10mg
56
Prolonged-release tablets
428-8205
Download
Download
40mg/20mg
56
Prolonged-release tablets
428-8239
Download
Download
Downloads
PIL 5mg/2.5mg
SmPC 5mg/2.5mg
PIL 10mg/5mg
SmPC 10mg/5mg
PIL 20mg/10mg
SmPC 20mg/10mg
PIL 40mg/20mg
SmPC 40mg/20mg
English
English
Deutsch
Español
Français
Italiano
Polski
Svenska
Suomi
Português
Română
Slovenščina
Slovenčina
Nederlands
Dansk
Ελληνικά
Čeština
Magyar
Lietuvių
Latviešu
Eesti
Hrvatski
Gaeilge
Български
Norsk
Türkçe
Bahasa Indonesia
Português (Brasil)
日本語
한국어
简体中文
العربية
Русский
हिन्दी
Українська
Srpski
Accessibility Adjustments
Powered by
OneTap
Select your accessibility profile
Vision Impaired Mode
Enhances website's visuals
Seizure Safe Profile
Clear flashes & reduces color
ADHD Friendly Mode
Focused browsing, distraction-free
Blindness Mode
Reduces distractions, improves focus
Epilepsy Safe Mode
Dims colors and stops blinking
Content
Bigger Text
Cursor
Line Height
Letter Spacing
Readable Font
Dyslexic Font
Align Text
Text Magnifier
Highlight Links
Colors
Invert Colors
Brightness
Contrast
Grayscale
Saturation
Orientation
Reading Line
Keyboard Navigation
Highlight Titles
Reading Mask
Hide Images
Highlight Al
Read Page
Mute Sounds
Stop Animations
Reset Settings